EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Type 2 Diabetes Prevention Programs—From Proof-of-Concept Trials to National Intervention and Beyond

Jaakko Tuomilehto iD, Matti Uusitupa iD, Edward W Gregg, Jaana Lindström iD

Journal of Clinical Medicine · 27.02.2023 · 12 (5) · 1876

DOI: 10.3390/jcm12051876 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 27.02.2023. Verfasst von Jaakko Tuomilehto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Unit, Finnish Institute for Health and Welfare, Mannerheimintie 166, 00271 Helsinki, Finland. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Foundation Ireland, Academy of Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevention of type 2 diabetes (T2D) in high-risk people with lifestyle interventions has been demonstrated by several randomized controlled trials. The intervention effect has sustained up to 20 years in post-trial monitoring of T2D incidence. In 2000, Finland launched the national T2D prevention plan. For screening for high T2D risk, the non-laboratory Finnish Diabetes Risk Score was developed and widely used, also in other countries. The incidence of drug-treated T2D has decreased steadily since 2010. The US congress authorized public funding for a national diabetes prevention program (NDPP) in 2010. It was built around a 16-visit program that relies on referral from primary care and self-referral of persons with either prediabetes or by a diabetes risk test. The program uses a train-the-trainer program. In 2015 the program started the inclusion of online programs. There has been limited implementation of nationwide T2D prevention programs in other countries. Despite the convincing results from RCTs in China and India, no translation to the national level was introduced there. T2D prevention efforts in low-and middle-income countries are still limited, but results have been promising. Barriers to efficient interventions are greater in these countries than in high-income countries, where many barriers also exist. Health disparities by socioeconomic status exist for T2D and its risk factors and form a challenge for preventive interventions. It seems that a stronger commitment to T2D prevention is needed, such as the successful WHO Framework Convention on Tobacco Control, which legally binds the countries to act.

Schlagwörter

Stichwörter der Autor:innen

diabetes preventionimpaired glucose tolerancenational implementationproof-of-concept trials

Autor:innen und Institutionen

  • Population Health Unit, Finnish Institute for Health and Welfare, Mannerheimintie 166, 00271 Helsinki, Finland.
  • Department of Public Health, University of Helsinki, 00100 Helsinki, Finland.
  • Diabetes Research Group, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Institute of Public Health and Clinical Nutrition, University of Eastern Finland, 70210 Kuopio, Finland.
  • School of Population Health, Royal College of Surgeons of Ireland, University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland.
  • Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London SW7 2AZ, UK.

ORCID-Profile: Jaakko Tuomilehto, Matti Uusitupa, Jaana Lindström

Förderung

  • Science Foundation Ireland
  • Academy of Finland

Zitieren

APA

Tuomilehto, J., Uusitupa, M., Gregg, E. W., & Lindström, J. (2023). Type 2 Diabetes Prevention Programs—From Proof-of-Concept Trials to National Intervention and Beyond. Journal of Clinical Medicine, 12(5), 1876. https://doi.org/10.3390/jcm12051876

Vancouver

Tuomilehto J, Uusitupa M, Gregg EW, Lindström J. Type 2 Diabetes Prevention Programs—From Proof-of-Concept Trials to National Intervention and Beyond. Journal of Clinical Medicine. 2023;12(5):1876. doi:10.3390/jcm12051876

BibTeX
@article{Tuomilehto2023,
  author = {Tuomilehto, Jaakko and Uusitupa, Matti and Gregg, Edward W and Lindström, Jaana},
  title = {Type 2 Diabetes Prevention Programs—From Proof-of-Concept Trials to National Intervention and Beyond},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {5},
  pages = {1876},
  doi = {10.3390/jcm12051876}
}
Kostenlos starten →